Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142064 · ClinicalTrials.gov registry record · Phase 2
A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures
A Phase 2 study of Kidney Diseases and Urinary Tract Infection, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00142064: Completed Phase 2 study of Kidney Diseases and Urinary Tract Infection, sponsored by Children's Mercy Hospital Kansas City.
NCT00142064 is a Phase 2 study of Kidney Diseases and Urinary Tract Infection that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 200 participants, below the 1,780-participant average among 38 other Kidney Diseases trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00142064, a Phase 2 study of Kidney Diseases and Urinary Tract Infection, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if a single application of Lidocaine gel topical anesthesia is as effective in decreasing the discomfort associated with urinary catheterization as two applications, within our pediatric population. Currently, two applications is our standard of care within our pediatric Radiology Department. Urinary catheterization is the process of placing a flexible tube into the urinary opening (urethra), to drain urine or instill radiographic solution for study of the anatomy and/or function of the urinary system. Members of the study team hypothesize equivalence in the observer reported catheterization pain scores as measured by the FLACC pain scale. The study is designed to obtain conclusive data to guide clinical practice. The study team hypothesizes that statistically similar levels of analgesia will be observed with the single application procedure as compared to the multiple application technique.
Conditions Studied
Interventions
- BEHAVIORAL observed levels of pain
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
What the finished NCT00142064 record still lists
NCT00142064 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,780-participant average among 38 other Kidney Diseases trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which observed levels of pain is the first listed.
NCT00142064 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00142064 about?
NCT00142064 is a clinical study titled "A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures". The purpose of this study is to determine if a single application of Lidocaine gel topical anesthesia is as effective in decreasing the discomfort associated with urinary catheterization as two applications, within our pediatric population. Currently, two applications is our standard of care within ...
What is the current status of trial NCT00142064?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2005-08. Estimated completion is 2007-04.
What conditions does trial NCT00142064 study?
This clinical trial studies the following conditions: Kidney Diseases, Urinary Tract Infection, Ureteral Diseases, Ureteral Obstruction.
What interventions are being tested in trial NCT00142064?
The interventions under investigation include: observed levels of pain (BEHAVIORAL).
Who is sponsoring clinical trial NCT00142064?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00142064 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00142064's enrollment target sits among peer trials
200 15th of 38 higher than 23 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
COMPLETED · Phase 2
-
Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
COMPLETED · Phase 2
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia